Metabolomics for Informing Adverse Outcome Pathways: Androgen Receptor Activation and the Pharmaceutical Spironolactone - Davis et al. 2017_Input Files.xlsx

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

About this Resource

Last updated	unknown
Created	unknown
Name	Davis et al. 2017_Input Files.xlsx
Format	MS Excel File
License	other-license-specified
Created	5 years ago
Media type	application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
has views	False
id	4afe3130-29d8-4e1d-be2a-8d1ec1c6b5e0
metadata modified	5 years ago
package id	dc7d8b88-c137-483e-aa88-5b8c0bb842b5
position	0
state	active
tracking summary	{'total': 0, 'recent': 0}